Optimization of cells for endogenous gene activation
AssigneeRoche Diagnostics GmbH
InventorsKonrad Honold, Thomas Holtschke, Anne Stern
Life of this patent
Estimating the term…
Loading patent…
AssigneeRoche Diagnostics GmbH
InventorsKonrad Honold, Thomas Holtschke, Anne Stern
Estimating the term…
The invention concerns a process for optimizing the gene expression in cells. A first aspect concerns a process for changing the expression of a nucleic acid sequence which is present endogenously in a eukaryotic cell by introduction of a heterologous expression control sequence into the genome of the cell by means of homologous recombination as well as site-specific recombinase-mediated excision of inserted foreign DNA and its replacement by further heterologous expression control sequences or/and amplification genes. In addition the invention concerns the introduction of one or several nucleic acid sequences to which an activator protein or an activator protein complex binds e.g. a hypoxia-inducible factor (HIF), into the genome of a eukaryotic cell by homologous recombination in order to change the expression of a target gene. Furthermore the invention concerns a process for testing the influence of 5′ or 3′ non-coding nucleic acid fragments on the expression of a target gene by determining the expression of a reporter gene. In addition the invention concerns a process for providing a DHFR-negative eukaryotic cell containing a recombinase target sequence as well as the expression of a nucleic acid sequence inserted into the recombinase target sequence.
A process for changing the expression of a nucleic acid sequence which is present endogenously in a eukaryotic cell, the method comprising
A vector suitable for homologous recombination, comprising the following sequences
A vector, comprising
A eukaryotic cell, comprising
A process for changing the expression of a nucleic acid sequence which is present endogenously in a eukaryotic cell, the method comprising
A vector suitable for homologous recombination, comprising
A eukaryotic cell, comprising at least one chromosomally-located exogenous nucleic acid sequence which binds an activator protein/activator protein complex which is operatively linked with a gene which is present endogenously in the cell.
A process for testing the influence of non-coding nucleic acid sequences from the region of a target gene present endogenously in a eukaryotic cell on its expression, the process comprising
A process for obtaining a DHFR-negative eukaryotic cell, the process comprising
A vector, comprising
A vector suitable for homologous recombination, comprising
A mammalian cell, comprising
A mammalian cell, comprising a heterologous nucleic acid sequence in the region of an endogenous DHFR gene locus, the heterologous sequence comprising
Dependencies are inferred from the claim text.